Back to search
IGT - Impaired Glucose Tolerance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which IGT - Impaired Glucose Tolerance trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which IGT - Impaired Glucose Tolerance trials you may qualify forThe goal of this clinical trial is to prevent the change from prediabetes (a pre-stage of type 2 diabetes mellitus (T2DM)) to T2DM in participants with prediabe…
This 12-week, double-blind, placebo-controlled trial will examine whether daily supplementation with the Lab4P probiotic can improve cognitive performance and m…
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improv…
The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, a…
Night shift work is associated with an increased risk of obesity, insulin resistance, and cardiometabolic disorders, largely due to circadian misalignment, disr…
We recently demonstrated that blockade of Glucagon-Like Peptide-1's (GLP-1) receptor (GLP1R) results in changes in islet function without changes in circulating…
The purpose of this clinical trial is to find out whether one type of fish oil works better than another at improving metabolic health in people who are at high…
In the Netherlands, patients admitted to the ICU are classified as having diabetes based on whether their medical records indicate glucose management medication…
This multicenter, randomized, double-blind, placebo-controlled trial aims to evaluate the efficacy and safety of Chiglitazar Sodium combined with lifestyle inte…